Literature DB >> 30804516

Time to revisit oligodendrocytes in multiple sclerosis.

Klaus-Armin Nave1, Hannelore Ehrenreich2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 30804516     DOI： 10.1038/s41591-019-0388-4

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  4 in total

Review 1.  The mechanistic target of rapamycin as a regulator of metabolic function in oligodendroglia during remyelination.

Authors:  Marie L Mather; Marisa A Jeffries; Teresa L Wood
Journal:  Curr Opin Pharmacol       Date:  2022-03-01       Impact factor: 5.547

2.  Lesion stage-dependent causes for impaired remyelination in MS.

Authors:  Katharina Heß; Laura Starost; Nicholas W Kieran; Christian Thomas; Maria C J Vincenten; Jack Antel; Gianvito Martino; Inge Huitinga; Luke Healy; Tanja Kuhlmann
Journal:  Acta Neuropathol       Date:  2020-07-24       Impact factor: 17.088

3.  A Matter of Choice: Inhibition of c-Rel Shifts Neuronal to Oligodendroglial Fate in Human Stem Cells.

Authors:  Lucia Mercedes Ruiz-Perera; Johannes Friedrich Wilhelm Greiner; Christian Kaltschmidt; Barbara Kaltschmidt
Journal:  Cells       Date:  2020-04-22       Impact factor: 6.600

Review 4.  The Current Challenges for Drug Discovery in CNS Remyelination.

Authors:  Sonia Balestri; Alice Del Giovane; Carola Sposato; Marta Ferrarelli; Antonella Ragnini-Wilson
Journal:  Int J Mol Sci       Date:  2021-03-12       Impact factor: 5.923
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.